Cargando…

Intravenous Administration of Manuka Honey Inhibits Tumor Growth and Improves Host Survival When Used in Combination with Chemotherapy in a Melanoma Mouse Model

Manuka honey has been recognized for its anti-bacterial and wound-healing activity but its potential antitumor effect is poorly studied despite the fact that it contains many antioxidant compounds. In this study, we investigated the antiproliferative activity of manuka honey on three different cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez-Cabezudo, Maria J., El-Kharrag, Rkia, Torab, Fawaz, Bashir, Ghada, George, Junu A., El-Taji, Hakam, al-Ramadi, Basel K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567021/
https://www.ncbi.nlm.nih.gov/pubmed/23409104
http://dx.doi.org/10.1371/journal.pone.0055993
_version_ 1782258643900563456
author Fernandez-Cabezudo, Maria J.
El-Kharrag, Rkia
Torab, Fawaz
Bashir, Ghada
George, Junu A.
El-Taji, Hakam
al-Ramadi, Basel K.
author_facet Fernandez-Cabezudo, Maria J.
El-Kharrag, Rkia
Torab, Fawaz
Bashir, Ghada
George, Junu A.
El-Taji, Hakam
al-Ramadi, Basel K.
author_sort Fernandez-Cabezudo, Maria J.
collection PubMed
description Manuka honey has been recognized for its anti-bacterial and wound-healing activity but its potential antitumor effect is poorly studied despite the fact that it contains many antioxidant compounds. In this study, we investigated the antiproliferative activity of manuka honey on three different cancer cell lines, murine melanoma (B16.F1) and colorectal carcinoma (CT26) as well as human breast cancer (MCF-7) cells in vitro. The data demonstrate that manuka honey has potent anti-proliferative effect on all three cancer cell lines in a time- and dose-dependent manner, being effective at concentrations as low as 0.6% (w/v). This effect is mediated via the activation of a caspase 9-dependent apoptotic pathway, leading to the induction of caspase 3, reduced Bcl-2 expression, DNA fragmentation and cell death. Combination treatment of cancer cells with manuka and paclitaxel in vitro, however, revealed no evidence of a synergistic action on cancer cell proliferation. Furthermore, we utilized an in vivo syngeneic mouse melanoma model to assess the potential effect of intravenously-administered manuka honey, alone or in combination with paclitaxel, on the growth of established tumors. Our findings indicate that systemic administration of manuka honey was not associated with any alterations in haematological or clinical chemistry values in serum of treated mice, demonstrating its safety profile. Treatment with manuka honey alone resulted in about 33% inhibition of tumor growth, which correlated with histologically observable increase in tumor apoptosis. Although better control of tumor growth was observed in animals treated with paclitaxel alone or in combination with manuka honey (61% inhibition), a dramatic improvement in host survival was seen in the co-treatment group. This highlights a potentially novel role for manuka honey in alleviating chemotherapy-induced toxicity.
format Online
Article
Text
id pubmed-3567021
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35670212013-02-13 Intravenous Administration of Manuka Honey Inhibits Tumor Growth and Improves Host Survival When Used in Combination with Chemotherapy in a Melanoma Mouse Model Fernandez-Cabezudo, Maria J. El-Kharrag, Rkia Torab, Fawaz Bashir, Ghada George, Junu A. El-Taji, Hakam al-Ramadi, Basel K. PLoS One Research Article Manuka honey has been recognized for its anti-bacterial and wound-healing activity but its potential antitumor effect is poorly studied despite the fact that it contains many antioxidant compounds. In this study, we investigated the antiproliferative activity of manuka honey on three different cancer cell lines, murine melanoma (B16.F1) and colorectal carcinoma (CT26) as well as human breast cancer (MCF-7) cells in vitro. The data demonstrate that manuka honey has potent anti-proliferative effect on all three cancer cell lines in a time- and dose-dependent manner, being effective at concentrations as low as 0.6% (w/v). This effect is mediated via the activation of a caspase 9-dependent apoptotic pathway, leading to the induction of caspase 3, reduced Bcl-2 expression, DNA fragmentation and cell death. Combination treatment of cancer cells with manuka and paclitaxel in vitro, however, revealed no evidence of a synergistic action on cancer cell proliferation. Furthermore, we utilized an in vivo syngeneic mouse melanoma model to assess the potential effect of intravenously-administered manuka honey, alone or in combination with paclitaxel, on the growth of established tumors. Our findings indicate that systemic administration of manuka honey was not associated with any alterations in haematological or clinical chemistry values in serum of treated mice, demonstrating its safety profile. Treatment with manuka honey alone resulted in about 33% inhibition of tumor growth, which correlated with histologically observable increase in tumor apoptosis. Although better control of tumor growth was observed in animals treated with paclitaxel alone or in combination with manuka honey (61% inhibition), a dramatic improvement in host survival was seen in the co-treatment group. This highlights a potentially novel role for manuka honey in alleviating chemotherapy-induced toxicity. Public Library of Science 2013-02-07 /pmc/articles/PMC3567021/ /pubmed/23409104 http://dx.doi.org/10.1371/journal.pone.0055993 Text en © 2013 Fernandez-Cabezudo et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fernandez-Cabezudo, Maria J.
El-Kharrag, Rkia
Torab, Fawaz
Bashir, Ghada
George, Junu A.
El-Taji, Hakam
al-Ramadi, Basel K.
Intravenous Administration of Manuka Honey Inhibits Tumor Growth and Improves Host Survival When Used in Combination with Chemotherapy in a Melanoma Mouse Model
title Intravenous Administration of Manuka Honey Inhibits Tumor Growth and Improves Host Survival When Used in Combination with Chemotherapy in a Melanoma Mouse Model
title_full Intravenous Administration of Manuka Honey Inhibits Tumor Growth and Improves Host Survival When Used in Combination with Chemotherapy in a Melanoma Mouse Model
title_fullStr Intravenous Administration of Manuka Honey Inhibits Tumor Growth and Improves Host Survival When Used in Combination with Chemotherapy in a Melanoma Mouse Model
title_full_unstemmed Intravenous Administration of Manuka Honey Inhibits Tumor Growth and Improves Host Survival When Used in Combination with Chemotherapy in a Melanoma Mouse Model
title_short Intravenous Administration of Manuka Honey Inhibits Tumor Growth and Improves Host Survival When Used in Combination with Chemotherapy in a Melanoma Mouse Model
title_sort intravenous administration of manuka honey inhibits tumor growth and improves host survival when used in combination with chemotherapy in a melanoma mouse model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567021/
https://www.ncbi.nlm.nih.gov/pubmed/23409104
http://dx.doi.org/10.1371/journal.pone.0055993
work_keys_str_mv AT fernandezcabezudomariaj intravenousadministrationofmanukahoneyinhibitstumorgrowthandimproveshostsurvivalwhenusedincombinationwithchemotherapyinamelanomamousemodel
AT elkharragrkia intravenousadministrationofmanukahoneyinhibitstumorgrowthandimproveshostsurvivalwhenusedincombinationwithchemotherapyinamelanomamousemodel
AT torabfawaz intravenousadministrationofmanukahoneyinhibitstumorgrowthandimproveshostsurvivalwhenusedincombinationwithchemotherapyinamelanomamousemodel
AT bashirghada intravenousadministrationofmanukahoneyinhibitstumorgrowthandimproveshostsurvivalwhenusedincombinationwithchemotherapyinamelanomamousemodel
AT georgejunua intravenousadministrationofmanukahoneyinhibitstumorgrowthandimproveshostsurvivalwhenusedincombinationwithchemotherapyinamelanomamousemodel
AT eltajihakam intravenousadministrationofmanukahoneyinhibitstumorgrowthandimproveshostsurvivalwhenusedincombinationwithchemotherapyinamelanomamousemodel
AT alramadibaselk intravenousadministrationofmanukahoneyinhibitstumorgrowthandimproveshostsurvivalwhenusedincombinationwithchemotherapyinamelanomamousemodel